Semma Therapeutics
Latest round
- Series B
Last raised
- Nov 2017
Total raised
- $129M
Investors
- 12
About Semma Therapeutics
Semma Therapeutics, Inc.Founded in 2014 and headquartered in Cambridge, US, Semma Therapeutics, Inc. specializes in developing cell-based therapies for diabetes. The company was acquired by Vertex Pharmaceuticals Incorporated in a deal valued at USD 950 mn, which closed in the fourth quarter of 2019. The acquisition aimed to leverage Semma's expertise in cell therapy to enhance Vertex's portfolio.Semma Therapeutics focuses on developing innovative cell therapies aimed at treating diabetes, particularly type 1 diabetes. The company is pioneering the use of encapsulated insulin-producing cells to restore natural insulin production in patients, thus potentially reducing their dependency on external insulin sources.As a biotechnology company, Semma Therapeutics generates revenue through strategic partnerships and potential future product sales once its therapies are brought to market.Following its acquisition by Vertex Pharmaceuticals, Semma Therapeutics is poised for significant growth through the development of its cell-based therapies for diabetes. Vertex intends to expand Semma's reach into new markets, focusing on North America and Europe, with plans to advance clinical trials in these regions in the coming years.
Who invested in Semma Therapeutics
12 investors across 2 rounds
See all investors in Semma Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Semma Therapeutics
Who invested in Semma Therapeutics?
Semma Therapeutics has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Semma Therapeutics raised?
Semma Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Semma Therapeutics last raise money?
Semma Therapeutics's most recent round on record is a Series B, in Nov 2017.
What does Semma Therapeutics do?
Semma Therapeutics is a biotechnology company.
Where is Semma Therapeutics headquartered?
Semma Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Semma Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Semma Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Semma Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.